Leadless Versus Transvenous Single‐Chamber Ventricular Pacemakers: Real‐World Evidence From Aveir VR Coverage With Evidence Development Study [PDF]
Background Aveir VR, a helix‐fixation leadless pacemaker (LP), was US Food and Drug Administration (FDA)‐approved in 2022. The performance of this novel LP has not been evaluated against transvenous single chamber ventricular pacemakers (TV‐VVI) in a ...
Anne Kroman
exaly +4 more sources
Atrial placement of Aveir-VR leadless pacemaker in a patient with complex cardiac anatomy [PDF]
Leadless pacemakers have provided new treatment modalities that can be especially useful in patients with complex cardiac anatomy and contraindications toward other pacemaker approaches.
Daniel Cortez, Javier Aguayo
exaly +4 more sources
Safety and Efficacy of Aveir Leadless Pacemaker in Chinese Patients [PDF]
Background Aveir, as a newly approved leadless pacemaker (LP), has been increasingly adopted in clinical practice. However, its application in the Chinese population remains limited.
Qiang Xie, Ziguan Zhang, Wuyang Zheng
exaly +3 more sources
Case Report: Aveir implantation in an 8.7-year-old, 25-kg pediatric patient with mitochondrial disease via internal jugular vein [PDF]
IntroductionMitochondrial disorders frequently precipitate progressive conduction system degeneration, with complete heart block representing a critical therapeutic challenge in pediatric populations, which ultimately requires permanent pacemaker ...
Tiewei Lu
exaly +4 more sources
Atrial leadless pacemaker implant using Aveir VR in an adolescent with congenital heart disease [PDF]
Introduction: Pediatric patients with congenital heart disease repair may develop sinus node dysfunction. Leadless pacemakers have provided an alternative option to transvenous and epicardial device implants for pediatric patients in need of ventricular ...
Daniel Cortez
doaj +2 more sources
Retrievable leadless pacemakers (Aveir VR) may be beneficial in adult patients with congenital heart disease [PDF]
Introduction: Congenital heart disease may present in up to 1.6 % of newborns. Given high burden of pacing need in adult patients with repaired congenital heart disease and availability of different pacing options, more information on outcomes of newer ...
Zainab Syyeda Rahmat, Daniel Cortez
doaj +2 more sources
Computational analysis of intracardiac collision risk and optimal site for right ventricular leadless left bundle branch area pacing: A simulation study [PDF]
Background: Conduction system pacing with leadless left bundle branch area pacing (LBBAP) is a promising application of leadless pacemakers (L-PMs). However, the mechanical impact of the L-PM on intracardiac structures may worsen tricuspid regurgitation ...
Angela W.C. Lee, PhD +8 more
doaj +2 more sources
Leadless pacemakers have demonstrated potential as a transvenous pacing option in Adult Congenital Heart Disease patients. Aveir™ single-chamber (VR) leadless pacemakers have demonstrated safety in patients without congenital heart disease in a dual ...
Daniel Cortez
exaly +3 more sources
Dual-chamber leadless pacemaker implant via the RIJ after failed femoral vein implant in a 65-year-old patient with symptomatic bradycardia, with left IJ port and right-sided AV fistula [PDF]
Introduction: Sinus node dysfunction (SND) is a disorder defined by abnormal initiation and conduction of electrical signals from the sinoatrial node. The preferred first-line treatment for a patient with symptomatic SND is a permanent pacemaker implant.
Shivani Lawa +3 more
doaj +2 more sources
Successful Leadless Pacemaker Implantation After Lead Extraction in a Patient With Ventricular Septal Defect Patch [PDF]
Introduction Lead extraction and reimplantation in adult congenital heart disease (CHD) patients is challenging due to anatomical complexity. Case A 76‐year‐old man with prior ventricular septal defect (VSD) patch repair and pacemaker implantation ...
Keigo Misonou +11 more
doaj +2 more sources

